v3.25.4
Note 11 - Share Capital (Details Textual)
$ / shares in Units, $ in Thousands, $ in Millions
 6 Months Ended 12 Months Ended
Dec. 01, 2025
shares
Jun. 06, 2025
CAD ($)
$ / shares
shares
Nov. 30, 2025
CAD ($)
Nov. 30, 2025
CAD ($)
$ / shares
shares
Nov. 30, 2024
CAD ($)
$ / shares
shares
Dec. 13, 2025
USD ($)
Dec. 12, 2025
USD ($)
Dec. 08, 2025
CAD ($)
Dec. 08, 2025
USD ($)
Dec. 20, 2024
USD ($)
Nov. 24, 2023
USD ($)
Statement Line Items [Line Items]                      
Flow-through recovery       $ 101 $ 0            
Increase (decrease) in number of shares outstanding through exercise of options (in shares) | shares       656,751 271,189            
Weighted average share price (in CAD per share) | $ / shares       $ 2.11 $ 1.2            
Number of share options exercised in share-based payment arrangement       1,091,984 [1] 2,029,500 [2]            
Increase (decrease) in number of shares outstanding through exercise of options on net exercise basis (in shares) | shares       254,251 237,189            
Number of share options exercised on net exercise basis in share-based payment arrangement (in shares) | shares       689,484 1,995,500            
Share options 1 [member]                      
Statement Line Items [Line Items]                      
Expense from share-based payment transactions with employees and consultants       $ 1,259 $ 1,506            
Restricted shares [member]                      
Statement Line Items [Line Items]                      
Expense from share-based payment transactions with employees and consultants       $ 951 $ 523            
Major ordinary share transactions [member] | Restricted shares [member]                      
Statement Line Items [Line Items]                      
Increase (decrease) in number of shares outstanding through restriced share rights vested (in shares) | shares 418,750                    
Number of other equity instruments outstanding in share-based payment arrangement 195,329                    
ATM program [member]                      
Statement Line Items [Line Items]                      
Issue of equity, maximum distribution amount                     $ 50.0
Maximum aggregate gross sales proceeds of shares                     $ 50.0
Issue of equity, number of shares (in shares) | shares       13,033,493 10,873,320            
Proceeds from issuing shares       $ 21,319 $ 13,114            
Share issue related cost       533 328            
ATM program [member] | Major ordinary share transactions [member]                      
Statement Line Items [Line Items]                      
Maximum aggregate gross sales proceeds of shares           $ 10.1 $ 6.1 $ 50,000 $ 50.0 $ 50.0  
Flow-through share financing [member]                      
Statement Line Items [Line Items]                      
Proceeds from issuing shares   $ 500   $ 500 $ 0            
Number of shares issued (in shares) | shares   373,135                  
Shares issued, price per share 1 (in CAD per share) | $ / shares   $ 1.34                  
Flow-through premium liability, fair value   $ 101 $ 0                
Flow-through recovery     $ 101                
[1] During the year ended November 30, 2025, the Company issued 656,751 common shares at weighted average trading prices of $2.11. The Common shares were issued pursuant to the exercise of 1,091,984 share options, of which 254,251 common shares were issued pursuant to the exercise of 689,484 share options on a net exercise basis.
[2] During the year ended November 30, 2024, the Company issued 271,189 common shares at weighted average trading prices of $1.20. The Common shares were issued pursuant to the exercise of 2,029,500 share options, of which 237,189 common shares were issued pursuant to the exercise of 1,995,500 share options on a net exercise basis.